Davita Inc (DVA) Shares Sold by Rhumbline Advisers

Rhumbline Advisers decreased its holdings in shares of Davita Inc (NYSE:DVA) by 3.2% in the 1st quarter, HoldingsChannel reports. The fund owned 278,593 shares of the company’s stock after selling 9,100 shares during the period. Rhumbline Advisers’ holdings in Davita were worth $15,125,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Securian Asset Management Inc raised its stake in Davita by 1.7% during the fourth quarter. Securian Asset Management Inc now owns 12,961 shares of the company’s stock worth $667,000 after acquiring an additional 216 shares in the last quarter. CSat Investment Advisory L.P. raised its stake in Davita by 61.8% during the fourth quarter. CSat Investment Advisory L.P. now owns 581 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares in the last quarter. Moody National Bank Trust Division raised its stake in Davita by 0.3% during the first quarter. Moody National Bank Trust Division now owns 87,943 shares of the company’s stock worth $4,775,000 after acquiring an additional 248 shares in the last quarter. Country Club Trust Company n.a. raised its stake in Davita by 4.5% during the first quarter. Country Club Trust Company n.a. now owns 5,988 shares of the company’s stock worth $325,000 after acquiring an additional 259 shares in the last quarter. Finally, Contravisory Investment Management Inc. raised its stake in Davita by 8.2% during the fourth quarter. Contravisory Investment Management Inc. now owns 3,932 shares of the company’s stock worth $202,000 after acquiring an additional 298 shares in the last quarter. 90.78% of the stock is owned by hedge funds and other institutional investors.

Davita stock opened at $51.24 on Wednesday. Davita Inc has a 1 year low of $48.25 and a 1 year high of $79.11. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.12 and a quick ratio of 1.11. The company has a market capitalization of $8.52 billion, a PE ratio of 14.35, a PEG ratio of 0.54 and a beta of 1.28.

Davita (NYSE:DVA) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.91 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.04). Davita had a net margin of 1.15% and a return on equity of 13.96%. The firm had revenue of $2.74 billion during the quarter, compared to analyst estimates of $2.82 billion. During the same period in the prior year, the company earned $1.05 EPS. The business’s quarterly revenue was down 3.7% compared to the same quarter last year. On average, sell-side analysts predict that Davita Inc will post 4.26 EPS for the current fiscal year.

Several research firms have recently issued reports on DVA. Zacks Investment Research raised Davita from a “sell” rating to a “hold” rating in a research note on Friday, May 10th. Deutsche Bank lowered their price objective on Davita from $68.00 to $66.00 and set a “buy” rating for the company in a research note on Thursday, May 9th. SunTrust Banks reaffirmed a “hold” rating on shares of Davita in a research note on Wednesday, February 20th. Finally, Robert W. Baird lowered their price objective on Davita from $90.00 to $70.00 and set an “outperform” rating for the company in a research note on Friday, February 15th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $67.78.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by WKRB News and is the sole property of of WKRB News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.wkrb13.com/2019/05/15/davita-inc-dva-shares-sold-by-rhumbline-advisers.html.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Recommended Story: The Role of a Fiduciary and Individual Investors

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.